nylalanine (Pap), p-azidotetrafluorophenylalanine 4 (Fpap)
had only been reported in racemic form5e and its incorpora-
tion into peptide affinity labels appears to be unexplored.
To circumvent the shortcomings associated with the photo-
chemistry of Pap and to take advantage of the preferential
reactivity of fluorinated aryl azides we sought to develop a
means for incorporation of 4 into peptides using conventional
solid-phase synthesis. A diethylacetamidomalonate synthesis7
subtilisin in buffered DMSO/water were not fruitful,10 we
opted for a nonenzymatic basic hydrolysis of this group to
acid 3, followed by kinetic resolution via proteolytic cleavage
of the acetamide. Compound 3 was unreactive to carboxy-
peptidase A catalyzed hydrolysis,11 however Aspergillus
melleus acylase-I treatment12 while maintaining the pH over
the range 7-8 by titration afforded L-p-azidotetrafluorophe-
nylalanine 4 as a white precipitate with good ee (>95%, vide
infra). Conversion to the Fmoc derivative 5 was effected by
reaction with Fmoc-OSu.13
The enantiomeric purity of 4 was assessed by comparison
of the 1H NMR spectra of the Mosher amide derivatives, 6,
of the methyl ester of 4 with R-(+) and S-(-) R-methoxy-
R-trifluoromethylphenylacetic acid (MTPA).14 Both diaster-
eomers of 6 gave distinct NMR spectra, but were indistin-
guishable by TLC. The chemical shifts of the methyl ether
protons of the R-(+) and S-(-) MTPA derivatives of 4 were
3.34 and 3.49 ppm, respectively, consistent with the assign-
ment of an L stereochemistry at the R-carbon, as would be
predicted for this enzymatic resolution.15 Contamination of
4 with the isomer with a D configuration at the R-carbon
was not detectable in the NMR spectra of these derivatives.
Scheme 1a
a Conditions: (a) NaN3, 0.1 equiv of Bu4NN3, DMF, 80 °C; (b)
NaOH, H2O, MeOH; (c) Acylase-I, H2O.
was used for preparation of protected racemic pentafluo-
rophenylalanine derivative 1 with a view to introducing the
azide group by nucleophilic substitution. Although fluori-
nated aromatics are activated toward nucleophilic attack, it
was observed that 1 required comparatively forcing condi-
tions to bring the reaction to completion. Treatment of 1 with
NaN3 in refluxing acetone for 7 h resulted in no reaction.
Treatment under literature conditions5e of NaN3 in DMF at
55 °C for 20 h afforded mostly starting materials, as judged
by 19F NMR. By increasing the temperature to 80 °C and
addition of catalytic Bu4NN3 the reaction could be driven
essentially to completion,8 without excessive accumulation
of impurities arising from thermolysis of the product 2.
Reaction of commercially available FmocPhe(F5) under
similar conditions resulted in significant loss of the Fmoc
group, whereas unprotected Phe(F5) afforded an intractable
mixture of penta- and tetrafluoro species.
To test the ease with which p-azidotetrafluorophenylala-
nine could be incorporated, via 5, into peptides using
conventional solid-phase methodology,16 we prepared a 33
residue peptide, 7, based on the GCN4 leucine zipper
sequence where this residue was substituted at position 16.
This sequence was chosen as a representative peptide to test
the stability of the fluoroaryl azide group to a number of
coupling/Fmoc deprotection cycles, and to the TFA depro-
tection byproducts of a range of side chain protecting groups
commonly employed in Fmoc chemistry. Automated syn-
thesis was performed using diisopropylcarbodiimide/hy-
droxybenzotriazole for couplings and 50% piperidine in
(9) (a) Berger, A.; Smolarsky, M.; Kurn, N.; Bosshard, H. R. J. Org.
Chem. 1973, 38, 457. (b) Tong, J. H.; Petitclerc, C.; D’Iorio, A.; Benoiton,
N. L. Can. J. Biochem. 1971, 49, 877.
(10) Behrens C.; Nielsen J. N.; Fan, X.-J.; Doisy, X.; Kim, K.-H.;
Praetorius-Ibba, M.; Nielsen, P. E.; Ibba, M. Tetrahedron 2000, 56, 9443.
(11) (a) Rivier, J. E.; Porter, J.; Rivier, C. L.; Perrin, M.; Corrigan, A.;
Hook, W. A.; Siraganian, R. P.; Vale, W. W. J. Med. Chem. 1986, 29,
1846. (b) Fones, W. S. J. Biol. Chem. 1953, 204, 323.
(12) Chenault, H. K.; Dahmer, J.; Whitesides, G. M. J. Am. Chem. Soc.
1989, 111, 6354.
As attempts at removal of the ethyl ester group of 2 using
either R-chymotrypsin in water or DMF/water mixture,9 or
(6) (a) Godovikova, T. S.; Kolpashchikov, D. M.; Orlova, T. N.; Richter,
V. A.; Ivanova, T. M.; Grochovsky, S. L.; Nasedkina, T. V.; Victorova, L.
S.; Poletaev, A. I. Bioconj. Chem. 1999, 10, 529. (b) Wlassoff, W. A.;
Dobrikov, M. I.; Safronov, I. V.; Dudko, R. Y.; Bogachev, V. S.;
Kandaurova, V. V.; Shishkin, G. V.; Dymshits, G. M.; Lavrik, O. I. Bioconj.
Chem. 1995, 6, 352. (c) Venyaminova, A. G.; Repkova, M. N.; Ivanova,
T. M.; Dobrikov, M. I.; Bulygin, K. N.; Graifer, D. M.; Karpova, G. G.;
Zarytova, V. F Nucleosides Nucleotides 1995, 14, 1069.
(13) Ten Kortenaar, P. B. W.; Van Dijk, B. G.; Peeters, J. M.; Raaben,
B. J.; Adams, P. J. H. M.; Tesser, G. I. Int. J. Pept. Protein Res. 1986, 27,
398.
(7) (a) Leanna, M. R.; Morton, H. E. Tetrahedron Lett. 1993, 34, 4485.
(b) Krapcho, A. P. Synthesis 1982, 805. (c) Filler, R.; Ayyangar, N. R.;
Gustowski, W.; Kang, H. H. J. Org. Chem. 1969, 34, 534.
(8) Bra¨ndstro¨m, A.; Lamm, B.; Palmertz, I. Acta Chem. Scand. B 1974,
28, 699.
(14) Dale, J. A.; Dull, D. L.; Mosher, H. S. J. Org. Chem. 1969, 34,
2543.
(15) Yamaguchi, S. In Asymmetric Synthesis; Morrison, J. D., Ed.;
Academic Press: San Diego, CA., 1983, Chapter 7.
(16) Wellings, D. A.; Atherton, E. Methods Enzymol. 1997, 289, 44.
4468
Org. Lett., Vol. 4, No. 25, 2002